iXCells Biotechnologies specializes in preclinical drug discovery by providing disease-relevant cellular models, including iPSC-derived cell products and custom genome editing services. Their offerings enable researchers in academia and the pharmaceutical industry to conduct high-quality functional assays and accelerate the understanding of complex diseases.
Funding
Funding not disclosed
Founders
Product
Problem
Drug discovery for complex diseases is often hampered by the lack of physiologically relevant cellular models that accurately mimic in vivo conditions. Traditional cell lines and animal models may not fully capture the intricacies of human biology, leading to inaccurate preclinical results and potential drug development failures.
Solution
iXCells Biotechnologies addresses this challenge by providing disease-relevant cellular models and preclinical services to accelerate drug discovery. The company offers a comprehensive suite of cell products, including human and animal primary cells, as well as induced pluripotent stem cell (iPSC)-derived cells, that are well-characterized and ready for use in various applications. In addition, iXCells provides custom services such as iPSC reprogramming, genome editing, and in vitro assays, enabling researchers to create tailored cell models and conduct high-throughput screening. By offering both off-the-shelf and custom solutions, iXCells Biotechnologies empowers researchers to study complex diseases in more physiologically relevant systems, improving the accuracy and efficiency of preclinical drug discovery.
Target Audience
iXCells Biotechnologies serves researchers in academia and the pharmaceutical industry who are engaged in preclinical drug discovery and require high-quality, disease-relevant cellular models and custom research services.
Features
- Extensive catalog of cell products, including human and animal primary cells, and iPSC-derived cells
- iPSC-derived cell lines include neurons, astrocytes, muscle cells, and more
- Disease-specific cell models, such as NASH hepatic stellate cells and ALS motor neurons
- Custom iPSC reprogramming and differentiation services
- Genome editing services using CRISPR-Cas9 technology
- In vitro assay services, including cell-based assays and antisense oligonucleotide screening
- Expertise in multi-cellular model building and 3D liver model signaling studies
- Capability to perform compound screening for iPSC-derived neurons and human immune cells